Chemical Biology & Drug Design · 2012 · 12 citations · 12 references
MedicineMedicinal ChemistryPharmacologyOrganic ChemistryPharmacodynamicsStructure-activity RelationshipsCardiac PharmacotherapyCardiovascular PharmacodynamicsCardiovascular PharmacologyHemodynamic PharmacologyBiological Evaluation ReportCardiac Chronotropic FunctionCardiovascular Drug PharmacologyChronotropic RegulationInotropic RegulationMedicinal Chemistry ApplicationsPharmacodynamics Of Cardiovascular DrugsPositive Inotropic Agents
Two series of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties have been synthesized and evaluated for their positive inotropic activity by measuring left atrium stroke volume on isolated rabbit heart preparations. The majority of the derivatives exhibited better in vitro activity than the existing drug, milrinone, and 6-((4-(4-methoxyphenyl)piperazin-1-yl)methyl)tetrazolo[5,1-a]phthalazine. 8 m in particular was identified as the most potent with an increased stroke volume of 12.02 ± 0.20% (milrinone: 2.46 ± 0.07%) at a concentration of 3 × 10(-5) m. The chronotropic effects of the compounds that exhibited good potency were also evaluated.
12
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Milton Packer, Joseph R. Carver, Richard J. Rodeheffer et al. · New England Journal of Medicine · 1991 · 2.2K citations · Full text
Medicine, Cardiology, Pharmacology +17
GABA and epilepsy: basic concepts from preclinical research.
Karen Gale · PubMed · 1992 · 150 citations